A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants

ACL-508 - Chong Kun Dang, Archela

A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants (clinicaltrials.gov) - Dec 10, 2024 - P1 | N=40 | Recruiting | Sponsor: Chong Kun Dang Pharmaceutical
New P1 trial

http://clinicaltrials.gov/ct2/show/NCT06727396

Dec 10, 2024